Belimumab is not associated with COVID-19 mRNA vaccination failure in systemic lupus erythematosus
Rheumatology (Oxford)
.
2023 Mar 1;62(3):e34-e35.
doi: 10.1093/rheumatology/keac459.
Authors
Simone Cosima Boedecker-Lips
1
,
Paul Claßen
1
,
Daniel Kraus
1
,
Julia Weinmann-Menke
1
Affiliation
1
1st Department of Medicine, University Medical Center, Mainz, Germany.
PMID:
35972412
PMCID:
PMC9384795
DOI:
10.1093/rheumatology/keac459
No abstract available
MeSH terms
COVID-19*
Humans
Immunosuppressive Agents
Lupus Erythematosus, Systemic*
RNA, Messenger
Treatment Outcome
Vaccination
Substances
belimumab
Immunosuppressive Agents
RNA, Messenger